Skip to main content
CI logo

Cigna Corporation (CI) Stock: Price, Forecast & Analyst Target

Cigna Corporation (CI) — MoonshotScore 78/100 (Strong band), calculated Nov 18, 2026. Price $273.09 (-4.30%), as of the Nov 19, 2026 trading session; market cap $72.0B. Expected results Feb 4, 2027.

Educational signal · not a buy or sell recommendation · How to read this

$273.09 −$12.28 (-4.30%) Market Cap $72.0B

Cigna Corporation · CI · NYSE · Healthcare · Medical - Healthcare Plans

Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments.

Price as of Nov 19, 2026

Key Statistics

78 of 100

MoonshotScore v2 · Cigna (CI)

Strong
Business Quality Solid (70)
Financial Safety Okay (53)
Valuation Cheap (88)
Growth Durability Flat (55)
Momentum Surging (81)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

High quality, at a dirt-cheap price, though the balance sheet is only middling; the market is already moving on it. Business Quality: Solid; Financial Safety: Okay; Valuation: Cheap; Growth Durability: Flat; Momentum: Surging.

  • EPS beat 6 of the last 8 reports
  • expected results Feb 4, 2027
  • Altman Z 2.82 · Piotroski F 8

Helping: business quality, an attractive price, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for CI (57 recorded, newest six shown)
RecordedScoreBand
81Exceptional
81Exceptional
81Exceptional
81Exceptional
78Strong
78Strong

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$273.09
Change on the day-4.30%
52-week range$257.85–$318.05
Market capitalisation$72.0B—
Price / earnings (trailing)12.94
Shares traded on the day3.05M
Beta (volatility vs the S&P 500)0.3

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 19, 2026: low $244, high $307, latest $273. 4 reported quarters marked, 4 above and 0 below the recorded estimate. $307 $244 high $307 Feb 5, 2026 · Earnings results · reported above the recorded estimate · close $2921Apr 30, 2026 · Earnings results · reported above the recorded estimate · close $2832Jul 30, 2026 · Earnings results · reported above the recorded estimate · close $2793Nov 5, 2026 · Earnings results · reported above the recorded estimate · close $2944 Oct 17, 2025 Nov 19, 2026 · $273 $299Oct 17, 2025$244Oct 31, 2025$270Nov 14, 2025$277Nov 28, 2025$275Dec 12, 2025$277Dec 26, 2025$279Jan 9, 2026$279Jan 23, 2026$292Feb 6, 2026$280Feb 20, 2026$272Mar 6, 2026$263Mar 20, 2026$270Apr 2, 2026$279Apr 17, 2026$283May 1, 2026$285May 15, 2026$277May 29, 2026$298Jun 12, 2026$283Jun 26, 2026$293Jul 10, 2026$290Jul 24, 2026$282Aug 7, 2026$278Aug 21, 2026$283Sep 4, 2026$275Sep 18, 2026$271Oct 2, 2026$302Oct 16, 2026$298Oct 30, 2026$297Nov 13, 2026

Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.

Events behind the price

  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate

Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.

Upcoming events

As of

  1. Next results dueProvider estimate
How to read these dates

Estimated dates can change.

What to watch next

Other perspectives

Council score for Cigna (CI): perspectives

Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.

5-Factor Breakdown

Business Quality Moderate
Financial Safety Neutral
Valuation Strong
Growth Durability Neutral
Momentum Strong

Legends Council

4 lenses, 4 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Griffin-style lens (simulated) Ken Griffin Unfavorable read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Favorable read

Read on: Nov 20, 2026

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Undervalued
Profit Margin Weak
Revenue Growth Moderate
Debt/Equity Weak
ROE Moderate
Gross Margin Negative

Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

One of these lenses reads this company less favourably than the MoonshotScore does: Griffin-style lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.

On Nov 18, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Cigna (CI), and what does it report?

Short answer

Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Cigna Corporation (CI) is listed on NYSE. Healthcare / Medical Healthcare Plans SEC filing business address: Bloomfield, CT. It employs 66,685 people and is led by Brian C. Evanko. The market values it at $72.0B.

2 · Latest results

What do the latest results show for Cigna (CI)?

Short answer · as of

Against analyst estimates the company has EPS beat 6 of the last 8 reports.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Did results meet expectations?

Reported earnings and revenue alongside the estimates recorded by the provider.

Latest report · revenue
$73.68B Nov 5, 2026
Latest report · revenue estimate
$72.64B Nov 5, 2026
Latest report · revenue vs estimate
Above estimate Nov 5, 2026
Latest report · EPS vs estimate
Above estimate Nov 5, 2026
Report dateRevenue · reportedRevenue · estimateEPS · reportedEPS · estimate
Nov 5, 2026$73.68B$72.64B$7.9800$7.5200
Jul 30, 2026$71.67B$70.14B$7.7800$7.6000
Apr 30, 2026$68.49B$66.29B$7.7900$7.6000
Feb 5, 2026$72.47B$70.31B$8.0800$7.8800
How to read these figures

Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Sep 2025$69.52B$1.87B$7.02 (diluted)
Q4 FY2025$72.13B$1.23B$4.64 (diluted)
Q1 FY2026$68.29B$1.65B$6.26 (diluted)
Q2 FY2026$71.40B$1.66B$6.29 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Cigna (CI)?

Short answer

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway. The MoonshotScore pillars rate business quality, an attractive price, positive momentum as strengths. The distress and quality screens read Altman Z 2.82 · Piotroski F 8. Trailing ratios: ROE 15.6% · ROA 4.3% · current ratio 0.84.

4 · What to check next?

What should you watch next at Cigna (CI)?

Short answer · as of

The next earnings report is expected on Feb 4, 2027. Current published price targets run low $302.00 · high $400.00 · consensus $343.46 · median $340.00 against a quoted price of $273.09 (as of Nov 19, 2026).

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Cigna compare with its peers?

Short answer

Cigna's score ranks 9th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Oscar Health, Inc. (OSCR) Same industry, near in market value$27.57 Nov 18, 2026$8.57B97 5-pillar Nov 18, 2026
Regeneron Pharmaceuticals, Inc. (REGN) Named competitor$945.53 Nov 18, 2026$97.8B95 5-pillar Nov 18, 2026
Clover Health Investments, Corp. (CLOV) Same industry, near in market value$4.17 Nov 18, 2026$2.23B94 5-pillar Nov 18, 2026
Centene Corporation (CNC) Same industry, near in market value$65.62 Nov 19, 2026$32.5B91 5-pillar Nov 18, 2026
Elevance Health Inc. (ELV) Named competitor$400.84 Nov 18, 2026$86.6B88 5-pillar Nov 18, 2026
Cencora, Inc. (COR) Named competitor$341.25 Nov 19, 2026$65.1B86 5-pillar Nov 18, 2026
CVS Health Corporation (CVS) Named competitor$80.06 Nov 19, 2026$102B81 5-pillar Nov 18, 2026
Humana Inc. (HUM) Same industry, near in market value$385.78 Nov 18, 2026$46.3B79 5-pillar Nov 18, 2026
Cigna (CI) — this page$273.09$72.0B78
UnitedHealth Group Incorporated (UNH) Same industry, near in market value$349.91 Nov 18, 2026$314B76 5-pillar Nov 18, 2026
Alignment Healthcare, Inc. (ALHC) Same industry, near in market value$6.72 Nov 18, 2026$1.41B73 5-pillar Nov 18, 2026
Becton, Dickinson and Company (BDX) Named competitor$212.73 Nov 19, 2026$57.9B68 5-pillar Nov 18, 2026
Molina Healthcare, Inc. (MOH) Same industry, near in market value$206.56 Nov 18, 2026$10.8B68 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$302.00 – $400.00
Consensus target
$343.46
Median target
$340.00

Consensus record · Captured .

Measured against a quoted price of $273.09 (as of Nov 19, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Sep 3, 2026

Transactions
17
Identified insiders
6
Purchases
0
Sales
4
Other transactions
13

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held CI in their latest 13F filing, and what they did against the filing before it.

InvestorManager13F quarterPortfolio weightValueLast quarter
Bridgewater AssociatesFounded by Ray DalioQ3 20260.12%$28.59MAdded +19.7% shares

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Cigna (CI)?

Read these with our analysis →

Common Questions About CI (Healthcare)

These answers are editorial: 1 of these 8 answers is drawn from the CI research dossier (written May 10, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for CI?

CI carries the MoonshotScore stated above — the Strong band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Cigna Corporation operates as a global health service company, providing insurance and related products and services.

Is CI a good stock to buy?

Stock Expert AI does not rate CI buy, sell or hold. Cigna Corporation carries a MoonshotScore, in the Strong band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the CI stock price today?

The last price recorded for Cigna Corporation (CI), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the CI price target?

The analyst consensus price target for Cigna Corporation (CI), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

What does Cigna Corporation do?

Cigna Corporation is a global health service company that provides a wide range of insurance and related products and services. The Cigna Healthcare segment provides medical, dental, vision, and behavioral health plans.

What are the key factors to evaluate for CI?

Cigna Corporation (CI) holds a MoonshotScore in the high range. To weigh it, compare the trailing P/E under Price & valuation with the analyst view under Analyst targets & estimates on this page. International Market Expansion: Cigna has the opportunity to expand its presence in international markets, particularly in regions with growing economies and increasing demand for healthcare services. Not financial advice.

How frequently does CI data refresh on this page?

CI's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven CI's recent stock price performance?

Cigna Corporation (CI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified service offerings through Evernorth and Cigna Healthcare. See the News tab for the latest drivers. Past performance does not predict future results.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 46 figures on this page — 1 from SEC filings and earnings calls, 37 from Financial Modeling Prep (FMP), 5 with no recorded source, 2 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.

ETFs that hold CI

Funds in our ETF coverage that list CI among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.

ETFWeightHoldings as of
IHF ETF5.15%